The Long Covid space has been abuzz with talk of Tollovid - the dietary supplement that is claimed to act, in much the same way as Paxlovid, on inhibiting 3CL protease.  We wanted to get some clear answers on how this supplement works, the potential benefits, and its safety profile.  We spoke to CEO of Todos Medical, Gerald Commissiong, who has brought this product to market, and Dr Dorit Arad, a biochemist and drug developer who has engineered Tollovid from her 28 years working in the field of protease inhibition in viruses. They were both keen to impress that this is a supplement and not a drug - they do not claim to prevent, treat, or cure Long Covid with Tollovid - but they suggest that there is anecdotal evidence that it helps.